{"tid":1074076,"cid":5,"subCid":0,"title":"【科技台】美國FDA將決定是否批准諾華肌肉萎縮症基因療法Zolgensma上市","createTime":"2019-03-23T06:46:24.000Z","updateTime":"2019-03-23T08:00:28.000Z","uid":120678,"like":3,"dislike":0,"uniUserReply":13,"replies":[{"pid":"c7d32c74e29473c6f440dcd0b1fc1558a670931a","tid":1074076,"uid":120678,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2019-03-23T06:46:24.000Z","msg":"<img src=\"https://www.gbimonthly.com/wp-content/uploads/2018/11/rtx14j87.jpg\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fwww.gbimonthly.com%2Fwp-content%2Fuploads%2F2018%2F11%2Frtx14j87.jpg&h=ba04964b&s={SIZE}\" /><br />\n<br />\n諾華(Novartis)日前宣布美國食品藥物管理局(FDA)已經接受生物製劑AVXS-101(正式名稱ZOLGENSMA &reg;)用於一次性基因替代治療脊髓性肌萎縮症（SMA）1型的優先審查，先前此藥已獲得突破性治療、孤兒藥稱號，預計將於2019年5月採取監管措施。 <br />\n<br />\n目前，Biogen開發的  Spinraza是 幾個國家唯一批准治療SMA的方法，包括  美國，歐盟，澳大利亞，巴西，日本，瑞士，韓國，加拿大和智利。Spinraza目前通過注射進入腦脊液，到達主要受SMA影響的中樞神經系統，它增加了 SMN2 基因產生全長SMN蛋白的能力，恢復其水平和功能。<br />\n<br />\n回顧SMA的發展，1891年首度由Werdnig報導，他認為肌肉無力症嚴重的程度會因人而異，經過一個世紀的發展，科學家將SMA分為三種類型，制定了標準的治療流程；1995年SMN基因也被確定是SMA的致病基因，在過去的20年越來越多的臨床治療方法被開發，也讓醫界激起了對治療SMA的信心。<br />\n<br />\n然而有成功，也有失敗的例子，今年6月羅氏(Roche)以1.2億歐元收購了Trophos的藥物，耗費3年的時間開發SMA治療方法，不得不承認在這開發的過程中遇到了很多難題，這些困難集中olesoxime最適合的劑量，以符合臨床III期的試驗。最後也宣布終止Olesoxime研究開發。<br />\n<br />\n諾華的AVXS-101是使用腺相關病毒載體9(Adeno-Associated Virus9, AAV9)做為載體，其能穿越血腦屏障，有效地靶向SMA1基因，並相較其他病毒載體具有更低的免疫抗原性(immunogenicity)，41名SMA1型的兒童患者中只有1名因對AAV9出現免疫反應而不能進行實驗，目前該療法已獲得FDA的快速通道、孤兒藥資格和突破性療法認證。<br />\n<br />\n在START試驗中，15名患者輸入ZOLGENSMA都存活，並且在24個月時無需進行永久性通氣。接受擬議ZOLGENSMA治療劑量的患者中有92％（11/12）可以獨立坐下&ge;5秒，這是SMA 1型自然史中從未實現的里程碑。過去治療歷史表明超過90％未治療的SMA 1型患者將在24個月後死亡或需要永久性通氣。<br />\n<br />\nAveXis執行長David Lennon表示，「作為一次性輸液，解決了SMA遺傳疾病重複給藥，ZOLGENSMA代表了這些患者及其家屬的重大治療進展。」<br />\n<br />\n不過，諾華早先也公布了ZOLGENSMA &reg;符合成本效益的治療定價，價格將落在400~500萬美元，看來一勞永逸的背後需要付出鉅款的代價。<br />\n<br />\n資料來源:<br />\n<a href=\"https://www.novartis.com/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-avxs-101-one-time-treatment-designed-address-genetic-root-cause-sma-type-1\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fwww.novartis.com%2Fnews%2Fmedia-releases%2Fnovartis-announces-fda-filing-acceptance-and-priority-review-avxs-101-one-time-treatment-designed-address-genetic-root-cause-sma-type-1&d=INFrb%2BpCZNVkt1J9J2ljECfe5Xzx4ME6JwL9AZsFK0I%3D&h=7972897c\" data-auto-link target=\"_blank\">https://www.novartis.com/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-avxs-101-one-time-treatment-designed-address-genetic-root-cause-sma-type-1</a>"},{"pid":"5edf450bbab574790f67ae1494f1b8d29b11c990","tid":1074076,"uid":3302,"like":1,"dislike":13,"score":-12,"citedBy":4,"replyTime":"2019-03-23T06:47:30.000Z","msg":"400m usd<img src=\"/assets/faces/lm2/dust.gif\" class=\"hkgmoji\" />"},{"pid":"6dc702dec9840104ef63fb561b8a1d1cbfc86039","tid":1074076,"uid":46943,"like":0,"dislike":1,"score":-1,"quote":{"pid":"5edf450bbab574790f67ae1494f1b8d29b11c990","tid":1074076,"uid":3302,"like":1,"dislike":13,"score":-12,"citedBy":4,"replyTime":"2019-03-23T06:47:30.000Z","msg":"400m usd<img src=\"/assets/faces/lm2/dust.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2019-03-23T07:19:39.000Z","msg":"無錢唔俾病<img src=\"/assets/faces/pig/smile.gif\" class=\"hkgmoji\" />"},{"pid":"907ea279ad925c72afd9d7b29f421b248783fcca","tid":1074076,"uid":29702,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2019-03-23T07:23:09.000Z","msg":"此回覆已被刪除"},{"pid":"ce5479dd73c8772a2f5c64134a0fa02cea232a5f","tid":1074076,"uid":39387,"like":6,"dislike":1,"score":5,"quote":{"pid":"5edf450bbab574790f67ae1494f1b8d29b11c990","tid":1074076,"uid":3302,"like":1,"dislike":13,"score":-12,"citedBy":4,"replyTime":"2019-03-23T06:47:30.000Z","msg":"400m usd<img src=\"/assets/faces/lm2/dust.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:26:44.000Z","msg":"4m usd呀on9<img src=\"/assets/faces/big/smile.gif\" class=\"hkgmoji\" />"},{"pid":"66dec9b1ad1d7486361e67ebb924752e806c6ccd","tid":1074076,"uid":58335,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2019-03-23T07:28:53.000Z","msg":"所以其實呢啲所謂新唔新療法出現都冇咩大影響<br />\n如果冇政府資助<br />\n普通人邊有可能食得起<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},{"pid":"5d9f3554019db329ca49e7c9a02a609f37c6d91b","tid":1074076,"uid":51701,"like":2,"dislike":0,"score":2,"quote":{"pid":"66dec9b1ad1d7486361e67ebb924752e806c6ccd","tid":1074076,"uid":58335,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2019-03-23T07:28:53.000Z","msg":"所以其實呢啲所謂新唔新療法出現都冇咩大影響<br />\n如果冇政府資助<br />\n普通人邊有可能食得起<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:33:02.000Z","msg":"唔應該為左一個人出咁多錢<img src=\"/assets/faces/normal/frown.gif\" class=\"hkgmoji\" />"},{"pid":"d46cae1526b9da153164756f9229f6ec1d05bf1f","tid":1074076,"uid":9315,"like":4,"dislike":2,"score":2,"quote":{"pid":"5edf450bbab574790f67ae1494f1b8d29b11c990","tid":1074076,"uid":3302,"like":1,"dislike":13,"score":-12,"citedBy":4,"replyTime":"2019-03-23T06:47:30.000Z","msg":"400m usd<img src=\"/assets/faces/lm2/dust.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2019-03-23T07:35:41.000Z","msg":"大陸落黎？<img src=\"/assets/faces/normal/clown.gif\" class=\"hkgmoji\" />"},{"pid":"99e445cec7733bb1354d4f39d7e3a39205eafaa3","tid":1074076,"uid":9315,"like":2,"dislike":0,"score":2,"quote":{"pid":"66dec9b1ad1d7486361e67ebb924752e806c6ccd","tid":1074076,"uid":58335,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2019-03-23T07:28:53.000Z","msg":"所以其實呢啲所謂新唔新療法出現都冇咩大影響<br />\n如果冇政府資助<br />\n普通人邊有可能食得起<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:37:34.000Z","msg":"梗係唔係  有技術就代表將來有降價空間  冇技術就乜都冇<br />\n況且400萬可能好多都係攤分返研發成本  話唔埋真正製造既成本好低"},{"pid":"f2fcf3bd73076d46db0d2cd6864e73f4d20f12a7","tid":1074076,"uid":48623,"like":1,"dislike":0,"score":1,"quote":{"pid":"99e445cec7733bb1354d4f39d7e3a39205eafaa3","tid":1074076,"uid":9315,"like":2,"dislike":0,"score":2,"quote":{"pid":"66dec9b1ad1d7486361e67ebb924752e806c6ccd","tid":1074076,"uid":58335,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2019-03-23T07:28:53.000Z","msg":"所以其實呢啲所謂新唔新療法出現都冇咩大影響<br />\n如果冇政府資助<br />\n普通人邊有可能食得起<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:37:34.000Z","msg":"梗係唔係  有技術就代表將來有降價空間  冇技術就乜都冇<br />\n況且400萬可能好多都係攤分返研發成本  話唔埋真正製造既成本好低"},"citedBy":1,"replyTime":"2019-03-23T07:40:54.000Z","msg":"等幾廿年專利過左咪平囉<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},{"pid":"1b208a6a6425ec46b88037883ff9ea5b06c42d93","tid":1074076,"uid":29702,"like":1,"dislike":0,"score":1,"citedBy":0,"replyTime":"2019-03-23T07:42:38.000Z","msg":"此回覆已被刪除"},{"pid":"59c18904c43f702e3eb22c284481519c09dc4733","tid":1074076,"uid":120678,"like":1,"dislike":0,"score":1,"quote":{"pid":"5d9f3554019db329ca49e7c9a02a609f37c6d91b","tid":1074076,"uid":51701,"like":2,"dislike":0,"score":2,"quote":{"pid":"66dec9b1ad1d7486361e67ebb924752e806c6ccd","tid":1074076,"uid":58335,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2019-03-23T07:28:53.000Z","msg":"所以其實呢啲所謂新唔新療法出現都冇咩大影響<br />\n如果冇政府資助<br />\n普通人邊有可能食得起<img src=\"/assets/faces/normal/sosad.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:33:02.000Z","msg":"唔應該為左一個人出咁多錢<img src=\"/assets/faces/normal/frown.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2019-03-23T07:44:20.000Z","msg":"記得之前有個香港SMA患者上過報紙，希望香港可以引入當時既新藥Spinraza<br />\n不過已經搵唔返篇報導<br />\nSpinraza要一世keep住將d藥打針落骨髓，個過程好invasive，而且隻藥都好貴，一年成本要600萬港幣<br />\n雖然Zolgensma要4M USD，但係佢係一針斷尾，唔駛keep住打，有人計過同用Spinraza一世既成本比其實係平左"},{"pid":"031c29f3024685b60177f1e8e80eead3e6244a63","tid":1074076,"uid":18012,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2019-03-23T07:50:38.000Z","msg":"睇左阿諾舒華"},{"pid":"69ba3eeef9d574204b21ded7912d7021fcd676e5","tid":1074076,"uid":143499,"like":0,"dislike":0,"score":0,"quote":{"pid":"ce5479dd73c8772a2f5c64134a0fa02cea232a5f","tid":1074076,"uid":39387,"like":6,"dislike":1,"score":5,"quote":{"pid":"5edf450bbab574790f67ae1494f1b8d29b11c990","tid":1074076,"uid":3302,"like":1,"dislike":13,"score":-12,"citedBy":4,"replyTime":"2019-03-23T06:47:30.000Z","msg":"400m usd<img src=\"/assets/faces/lm2/dust.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:26:44.000Z","msg":"4m usd呀on9<img src=\"/assets/faces/big/smile.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:52:53.000Z","msg":"m=萬<img src=\"/assets/faces/normal/clown.gif\" class=\"hkgmoji\" /><br />\nm=million<img src=\"/assets/faces/normal/smile.gif\" class=\"hkgmoji\" />"},{"pid":"307b69a5426d48c42245bdf1be8bfd6714683b48","tid":1074076,"uid":72009,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2019-03-23T07:59:39.000Z","msg":"可以獨立坐下&ge;5秒<br />\n<br />\n好過冇，但病人父母一定勁開心"},{"pid":"e5b184b586d087852d635391bc8799cb29ad7e02","tid":1074076,"uid":75804,"like":0,"dislike":0,"score":0,"quote":{"pid":"69ba3eeef9d574204b21ded7912d7021fcd676e5","tid":1074076,"uid":143499,"like":0,"dislike":0,"score":0,"quote":{"pid":"ce5479dd73c8772a2f5c64134a0fa02cea232a5f","tid":1074076,"uid":39387,"like":6,"dislike":1,"score":5,"quote":{"pid":"5edf450bbab574790f67ae1494f1b8d29b11c990","tid":1074076,"uid":3302,"like":1,"dislike":13,"score":-12,"citedBy":4,"replyTime":"2019-03-23T06:47:30.000Z","msg":"400m usd<img src=\"/assets/faces/lm2/dust.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:26:44.000Z","msg":"4m usd呀on9<img src=\"/assets/faces/big/smile.gif\" class=\"hkgmoji\" />"},"citedBy":1,"replyTime":"2019-03-23T07:52:53.000Z","msg":"m=萬<img src=\"/assets/faces/normal/clown.gif\" class=\"hkgmoji\" /><br />\nm=million<img src=\"/assets/faces/normal/smile.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2019-03-23T08:00:28.000Z","msg":"m=milliard<img src=\"/assets/faces/normal/angel.gif\" class=\"hkgmoji\" />"}]}